These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 19584708

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Induction of multidrug resistance associated protein 2 in tamoxifen-resistant breast cancer cells.
    Choi HK, Yang JW, Roh SH, Han CY, Kang KW.
    Endocr Relat Cancer; 2007 Jun; 14(2):293-303. PubMed ID: 17639045
    [Abstract] [Full Text] [Related]

  • 23. Factors affecting the sensitivity of T-47D human breast cancer cells to tamoxifen.
    Reddel RR, Murphy LC, Sutherland RL.
    Cancer Res; 1984 Jun; 44(6):2398-405. PubMed ID: 6722780
    [Abstract] [Full Text] [Related]

  • 24. Additive and synergistic effects of a novel antiestrogen, toremifene (Fc-1157a), and human interferons on estrogen responsive MCF-7 cells in vitro.
    Kangas L, Nieminen AL, Cantell K.
    Med Biol; 1985 Jun; 63(4):187-90. PubMed ID: 2419713
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Inhibition of human breast cancer cell proliferation with estradiol metabolites is as effective as with tamoxifen.
    Seeger H, Huober J, Wallwiener D, Mueck AO.
    Horm Metab Res; 2004 May; 36(5):277-80. PubMed ID: 15156405
    [Abstract] [Full Text] [Related]

  • 27. Effect of melatonin and all-trans retinoic acid on the proliferation and induction of the apoptotic pathway in the culture of human breast cancer cell line MCF-7.
    Czeczuga-Semeniuk E, Wołczyński S, Anchim T, Dziecioł J, Dabrowska M, Pietruczuk M.
    Pol J Pathol; 2002 May; 53(2):59-65. PubMed ID: 12140868
    [Abstract] [Full Text] [Related]

  • 28. The tamoxifen metabolite, endoxifen, is a potent antiestrogen that targets estrogen receptor alpha for degradation in breast cancer cells.
    Wu X, Hawse JR, Subramaniam M, Goetz MP, Ingle JN, Spelsberg TC.
    Cancer Res; 2009 Mar 01; 69(5):1722-7. PubMed ID: 19244106
    [Abstract] [Full Text] [Related]

  • 29. Liposomal 4-hydroxy-tamoxifen: effect on cellular uptake and resulting cytotoxicity in drug resistant breast cancer cells in vitro.
    Zeisig R, Teppke AD, Behrens D, Fichtner I.
    Breast Cancer Res Treat; 2004 Oct 01; 87(3):245-54. PubMed ID: 15528967
    [Abstract] [Full Text] [Related]

  • 30. Vitamin D, tamoxifen and beta-estradiol modulate breast cancer cell growth and interleukin-6 and metalloproteinase-2 production in three-dimensional co-cultures of tumor cell spheroids with endothelium.
    Paduch R, Kandefer-Szerszeń M.
    Cell Biol Toxicol; 2005 Oct 01; 21(5-6):247-56. PubMed ID: 16323060
    [Abstract] [Full Text] [Related]

  • 31. [Response to tamoxifen in estrogen receptor-positive cell line MCF-7 is independent of p53 expression].
    Shtam TA, Pantina RA, Varfolomeeva EIu, Filatov MV.
    Vopr Onkol; 2007 Oct 01; 53(2):194-9. PubMed ID: 17663174
    [Abstract] [Full Text] [Related]

  • 32. Synergistic effects of retinoic acid and tamoxifen on human breast cancer cells: proteomic characterization.
    Wang Y, He QY, Chen H, Chiu JF.
    Exp Cell Res; 2007 Jan 15; 313(2):357-68. PubMed ID: 17098229
    [Abstract] [Full Text] [Related]

  • 33. Estrogen signals via an extra-nuclear pathway involving IGF-1R and EGFR in tamoxifen-sensitive and -resistant breast cancer cells.
    Santen RJ, Fan P, Zhang Z, Bao Y, Song RX, Yue W.
    Steroids; 2009 Jul 15; 74(7):586-94. PubMed ID: 19138696
    [Abstract] [Full Text] [Related]

  • 34. Species-specific pharmacology of antiestrogens: role of metabolism.
    Jordan VC, Robinson SP.
    Fed Proc; 1987 Apr 15; 46(5):1870-4. PubMed ID: 3556610
    [Abstract] [Full Text] [Related]

  • 35. Effects of tamoxifen on DNA adduct formation and arylamines N-acetyltransferase activity in human breast cancer cells.
    Lee JH, Lu HF, Wang DY, Chen DR, Su CC, Chen YS, Yang JH, Chung JG.
    Res Commun Mol Pathol Pharmacol; 2004 Apr 15; 115-116():217-33. PubMed ID: 17564319
    [Abstract] [Full Text] [Related]

  • 36. Relevance of breast cancer antiestrogen resistance genes in human breast cancer progression and tamoxifen resistance.
    van Agthoven T, Sieuwerts AM, Meijer-van Gelder ME, Look MP, Smid M, Veldscholte J, Sleijfer S, Foekens JA, Dorssers LC.
    J Clin Oncol; 2009 Feb 01; 27(4):542-9. PubMed ID: 19075277
    [Abstract] [Full Text] [Related]

  • 37. Inhibition of vacuolar H+ ATPase enhances sensitivity to tamoxifen via up-regulation of CHOP in breast cancer cells.
    Jin HO, Lee YH, Kim HA, Kim EK, Noh WC, Kim YS, Hwang CS, Kim JI, Chang YH, Hong SI, Hong YJ, Park IC, Lee JK.
    Biochem Biophys Res Commun; 2013 Aug 02; 437(3):463-8. PubMed ID: 23838288
    [Abstract] [Full Text] [Related]

  • 38. Establishment of an in vitro estrogen-dependent mouse mammary tumor model: a new tool to understand estrogen responsiveness and development of tamoxifen resistance in the context of stromal-epithelial interactions.
    Pontiggia O, Rodriguez V, Fabris V, Raffo D, Bumaschny V, Fiszman G, de Kier Joffé EB, Simian M.
    Breast Cancer Res Treat; 2009 Jul 02; 116(2):247-55. PubMed ID: 18622696
    [Abstract] [Full Text] [Related]

  • 39. Electromagnetic fields alter the expression of estrogen receptor cofactors in breast cancer cells.
    Girgert R, Gründker C, Emons G, Hanf V.
    Bioelectromagnetics; 2008 Apr 02; 29(3):169-76. PubMed ID: 18027843
    [Abstract] [Full Text] [Related]

  • 40. Gene expression changes during the development of estrogen-independent and antiestrogen-resistant growth in breast cancer cell culture models.
    Pennanen PT, Sarvilinna NS, Ylikomi TJ.
    Anticancer Drugs; 2009 Jan 02; 20(1):51-8. PubMed ID: 19343000
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.